BCTX
BriaCell Therapeutics Corp.
NASDAQ · Healthcare · Biotechnology · CA
$3.19
+5.98%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-233.3%
Return on equity
-162.3%
Return on assets
-240.7%
Return on invested capital
0.00x
Asset turnover
-$31.7M
Cash from operations
$2.35
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jul 1, 2026